Advertisement

Reactions Weekly

, Volume 1756, Issue 1, pp 1–1 | Cite as

DOACs contraindicated in patients with APS

News item
  • 30 Downloads

Reference

  1. Cooper TP, et al. Apixaban (Eliquis), dabigatran etexilate (Pradaxa), edoxaban (Lixiana) and rivaroxaban (Xarelto) are not recommended in patients with antiphospholipid syndrome due to possible increased risk for recurrent thrombotic events. Internet Document : [3 pages], 20 May 2019. Available from: URL: https://www.hpra.ie/docs/default-source/default-document-library/important-safety-information

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations